Commercial's The New Drugs and Clinical Trials Rules 2019 Bare Act with Short Comments 2027 Edition

OVERVIEW

Commercial's The New Drugs and Clinical Trials Rules, 2019 is an exhaustive, authoritative statutory reference manual published by Commercial Law Publishers (India) Pvt. Ltd. in knowledge partnership with lexlegis.ai. Presenting the updated 2027 Edition (Book Code N-7A), this bare act with short comments delivers the complete unedited text governing clinical research, pharmaceutical testing, and drug regulation in India.

This volume is fully updated to incorporate vital statutory amendments, including amendments vide GSR 50(E), dt. 21-1-2026 (w.e.f. 21-4-2026) to the 2019 Rules. It also compiles The Medical Devices Rules, 2017 (as amended vide GSR 744(E), dt. 14-8-2026, w.e.f. 19-8-2026) and The Drugs and Cosmetics Act, 1940 (as amended by The Jan Vishwas (Amendment of Provisions) Act, 2026 with provisions effective June/July 2026).

As an essential pharmaceutical and health law reference work, this best law book India volume serves as an indispensable desk manual for pharmaceutical legal consultants, clinical research organizations (CROs), regulatory compliance officers, drug law litigators, candidates using it as a guide for judiciary exam preparation (specialized law papers), and law students India studying medical and drug jurisprudence.

KEY FEATURES

• Publisher & Knowledge Partner: Published by Commercial Law Publishers (India) Pvt. Ltd. in collaboration with lexlegis.ai.

• Edition & Code: 2027 Edition (Book Code N-7A).

• 2026 Rules Amendments: Fully updated with recent amendments under GSR 50(E) (w.e.f. 21-4-2026).

• Medical Devices Rules 2017 Integrated: Encloses the Medical Devices Rules 2017 updated with August 2026 amendments.

• Drugs and Cosmetics Act 1940 Included: Features the principal Act 1940 updated with Jan Vishwas Act 2026 amendments.

• Short Comments Included: Equipped with concise notes under important provisions for quick research.

• Binding Type: High-quality, durable Paperback edition, designed for continuous office consultation and regulatory practice.

WHAT THIS BOOK COVERS

• The New Drugs and Clinical Trials Rules, 2019:

  • Definitions, clinical trial approvals, ethics committee registration, and responsibilities of investigators and sponsors

  • Conduct of clinical trials, bioavailability and bioequivalence studies, NOCs, and compensation for trial-related injury or death

• The Medical Devices Rules, 2017:

  • Classification of medical devices, manufacturing licenses, import regulations, and clinical investigation norms

• The Drugs and Cosmetics Act, 1940:

  • Statutory definitions, import, manufacture, sale of drugs and cosmetics, standards of quality, and penalties (updated for Jan Vishwas Act 2026)

WHO SHOULD BUY

• Pharmaceutical Regulatory Professionals: Compliance officers and regulatory affairs managers handling drug approvals and clinical trials.

• Clinical Research Organizations (CROs): Investigators, researchers, and ethics committee members navigating trial protocols and statutory compliance.

• Healthcare & Drug Law Litigators: Advocates handling drug inspector prosecutions, manufacturing license suspensions, and pharmaceutical litigation.

• Law Students India: Scholars pursuing health law, intellectual property, and specialized commercial law diplomas.

WHY THIS BOOK 

• Comprehensive 3-in-1 Pharmaceutical Guide: Combines Clinical Trials Rules 2019, Medical Devices Rules 2017, and the Drugs and Cosmetics Act 1940 in one volume.

• Up-to-Date 2026 Amendments: Incorporates the latest January 2026 trial rule amendments and August 2026 medical device updates.

• High-Yield Short Comments: Point-to-point notes assist in rapid statutory interpretation.

PRODUCT DETAILS

• Title: Commercial's The New Drugs and Clinical Trials Rules, 2019 Bare Act with Short Comments

• Publisher: Commercial Law Publishers (India) Pvt. Ltd.

• Knowledge Partner: lexlegis.ai

• Language: English

• Edition: 2027 Edition

• Format: Paperback

• MRP: ₹695.00

BENEFITS

• Ensure Flawless Clinical Compliance: Master exact statutory rules governing human clinical trials and medical device testing.

• Navigate Regulatory Changes: Stay fully updated on recent 2026 rule revisions and Jan Vishwas Act modifications.

• Convenient Desk Companion: Compact paperback binding ensures easy handling during daily regulatory research.

CALL TO ACTION

Master Pharmaceutical & Clinical Law: Upgrade your regulatory and legal library with Commercial's updated 2027 Edition of The New Drugs and Clinical Trials Rules 2019. Order your copy today!